These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6759138)

  • 21. Penicillamine in ankylosing spondylitis: a double blind placebo controlled trial.
    Steven MM; Morrison M; Sturrock RD
    J Rheumatol; 1985 Aug; 12(4):735-7. PubMed ID: 3903158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid remission of treatment-resistant ankylosing spondylitis with etanercept--a drug for refractory ankylosing spondylitis?
    Barthel HR
    Arthritis Rheum; 2001 Aug; 45(4):404. PubMed ID: 11501730
    [No Abstract]   [Full Text] [Related]  

  • 23. Lung function in patients with ankylosing spondylitis. A study of the influence of disease activity and treatment with nonsteroidal antiinflammatory drugs.
    Franssen MJ; van Herwaarden CL; van de Putte LB; Gribnau FW
    J Rheumatol; 1986 Oct; 13(5):936-40. PubMed ID: 3546687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Double-blind trial of the therapeutic efficacy of voltaren and indomethacin in Bechterew's disease].
    Burdeĭnyĭ AP
    Ter Arkh; 1981; 53(7):107-11. PubMed ID: 7027508
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparison of naproxen and piroxicam in rheumatoid arthritis and Bechterew's syndrome. A double-blind parallel multicenter study].
    Myklebust G
    Tidsskr Nor Laegeforen; 1986 Jun; 106(17-18):1485-7. PubMed ID: 3532419
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ankylosing spondylitis. Comparative trial of two non-steroidal anti-inflammatory agents: pirprofen and ketoprofen].
    Renier JC; Fournier M; Loyau G; Roux H
    Nouv Presse Med; 1982 Aug; 11(33):2494-6. PubMed ID: 6752874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of a double-blind study with indomethacin and indoprofen, a new non-steroidal antirheumatic agent.
    Seigmund H; Schneider B
    Eur J Rheumatol Inflamm; 1981; 4(1):79-86. PubMed ID: 7042366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs.
    Song IH; Poddubnyy DA; Rudwaleit M; Sieper J
    Arthritis Rheum; 2008 Apr; 58(4):929-38. PubMed ID: 18383378
    [No Abstract]   [Full Text] [Related]  

  • 29. Meclofenamate sodium in the treatment of ankylosing spondylitis. Report of a European double-blind controlled multicenter study.
    Ebner W; Poal Ballarin JM; Boussina I
    Arzneimittelforschung; 1983; 33(4A):660-3. PubMed ID: 6349653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pirprofen in patients with arthrosis. Double-blind study versus indomethacin].
    Manz G
    Fortschr Med; 1985 Feb; 103(SPEC NO 7A):176-8. PubMed ID: 3872827
    [No Abstract]   [Full Text] [Related]  

  • 31. Prospects for disease modification in ankylosing spondylitis: do nonsteroidal antiinflammatory drugs do more than treat symptoms?
    Ward MM
    Arthritis Rheum; 2005 Jun; 52(6):1634-6. PubMed ID: 15934065
    [No Abstract]   [Full Text] [Related]  

  • 32. [The clinical efficacy and tolerance of a new anti-inflammatory agent, carprofen, in osteoarthritis. Comparative double-blind study with naproxen].
    Cozzolino F; Costa L; Marasco E
    Clin Ter; 1983 Sep; 106(6):435-9. PubMed ID: 6357596
    [No Abstract]   [Full Text] [Related]  

  • 33. Anterior optic neuropathy, Roth spots, and ankylosing spondylitis.
    Yülek F; Erten S; Orhan N; Simsek S
    J Clin Rheumatol; 2009 Sep; 15(6):309-10. PubMed ID: 19734740
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial.
    Santra G; Sarkar RN; Phaujdar S; Banerjee S; Siddhanta S
    Singapore Med J; 2010 Nov; 51(11):883-7. PubMed ID: 21140116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical experiences with the antirheumatism agent carprofen].
    Kaufmann S
    Med Welt; 1983 Dec; 34(48):1373-6. PubMed ID: 6656577
    [No Abstract]   [Full Text] [Related]  

  • 36. [Initial therapy of activated coxarthrosis and gonarthrosis using pirprofen. Double-blind study versus indomethacin].
    Bachmann F; Hartl PW
    Fortschr Med; 1985 Feb; 103(SPEC NO 7A):179-81. PubMed ID: 3872828
    [No Abstract]   [Full Text] [Related]  

  • 37. Double-blind multicentre, between patients comparison of indoprofen and indomethacin in rheumatoid arthritis patients under basic steroid treatment.
    del Campo JB
    Eur J Rheumatol Inflamm; 1981; 4(1):135-43. PubMed ID: 7042357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study.
    Sieper J; Klopsch T; Richter M; Kapelle A; Rudwaleit M; Schwank S; Regourd E; May M
    Ann Rheum Dis; 2008 Mar; 67(3):323-9. PubMed ID: 17616556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and tolerability of aceclofenac in the treatment of patients with ankylosing spondylitis: a multicenter controlled clinical trial. Aceclofenac Indomethacin Study Group.
    Batlle-Gualda E; Figueroa M; Ivorra J; Raber A
    J Rheumatol; 1996 Jul; 23(7):1200-6. PubMed ID: 8823693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of ankylosing and non-ankylosing spondylitis.
    Donnelly P
    Ir Med J; 1993; 86(6):175-6. PubMed ID: 8106217
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.